Dual receptor T cells mediate pathologic alloreactivity in patients with acute graft-versus-host disease

Science Translational Medicine

Volumn 5, Issue 188, 2013, Pages

  Morris, Gerald P ^a   Uy, Geoffrey L ^a   Donermeyer, David ^a   DiPersio, John F ^a   Allen, Paul M ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; MINOR HISTOCOMPATIBILITY ANTIGEN; T LYMPHOCYTE RECEPTOR;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CELL SURFACE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; GRAFT RECIPIENT; HLA MATCHING; HUMAN; HUMAN CELL; IMMUNOPATHOLOGY; IN VITRO STUDY; MOLECULAR CLONING; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYMPTOM; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANTIBODIES, MONOCLONAL; CYTOKINES; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; HLA ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 84880569064     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3005452     Document Type: Article

References (40)

1. W. D. Shlomchik, Graft-versus-host disease. Nat. Rev. Immunol. 7, 340-352 (2007).
2. J. M. Coghill, S. Sarantopoulos, T. P. Moran, W. J. Murphy, B. R. Blazar, J. S. Serody, Effector CD4+ T cells, the cytokines they generate, and GVHD: Something old and something new. Blood 117, 3268-3276 (2011).
3. B. R. Blazar, W. J. Murphy, M. Abedi, Advances in graft-versus-host disease biology and therapy. Nat. Rev. Immunol. 12, 443-458 (2012).
4. A. Bacigalupo, Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: Efficacy and side effects. Bone Marrow Transplant. 35, 225-231 (2005).
5. E. A. Copelan, Hematopoietic stem-cell transplantation. N. Engl. J. Med. 354, 1813-1826 (2006).
6. A. L. Amir, L. J. D'Orsogna, D. L. Roelen, M. M. van Loenen, R. S. Hagedoorn, R. de Boer, M. A. van der Hoorn, M. G. Kester, I. I. Doxiadis, J. H. Falkenburg, F. H. Claas, M. H. Heemskerk, Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115, 3146-3157 (2010).
7. J. J. Melenhorst, P. Scheinberg, A. Williams, D. R. Ambrozak, K. Keyvanfar, M. Smith, J. P. McCoy Jr., N. F. Hensel, D. C. Douek, A. J. Barrett, Alloreactivity across HLA barriers is mediated by both naïve and antigen-experienced T cells. Biol. Blood Marrow Transplant. 17, 800-809 (2011).
8. G. P. Morris, P. M. Allen, How the TCR balances sensitivity and specificity for the recognition of self and pathogens. Nat. Immunol. 13, 121-128 (2012).
9. E. Padovan, G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, A. Lanzavecchia, Expression of two T cell receptor a chains: Dual receptor T cells. Science 262, 422-424 (1993).
10. S. M. Alam, I. N. Crispe, N. R. Gascoigne, Allelic exclusion of mouse T cell receptor a chains occurs at the time of thymocyte TCR up-regulation. Immunity 3, 449-458 (1995).
11. X. He, C. A. Janeway Jr., M. Levine, E. Robinson, P. Preston-Hurlburt, C. Viret, K. Bottomly, Dual receptor T cells extend the immune repertoire for foreign antigens. Nat. Immunol. 3, 127-134 (2002).
12. M. Malissen, J. Trucy, F. Letourneur, N. Rebaï, D. E. Dunn, F. W. Fitch, L. Hood, B. Malissen, A T cell clone expresses two T cell receptor a genes but uses one ab heterodimer for allorecognition and self MHC-restricted antigen recognition. Cell 55, 49-59 (1988).
13. F. Hardardottir, J. L. Baron, C. A. Janeway Jr., T cells with two functional antigen-specific receptors. Proc. Natl. Acad. Sci. U.S.A. 92, 354-358 (1995).
14. G. P. Morris, P. M. Allen, Cutting edge: Highly alloreactive dual TCR T cells play a dominant role in graft-versus-host disease. J. Immunol. 182, 6639-6643 (2009).
15. T. Zal, S. Weiss, A. Mellor, B. Stockinger, Expression of a second receptor rescues self-specific T cells from thymic deletion and allows activation of autoreactive effector function. Proc. Natl. Acad. Sci. U.S.A. 93, 9102-9107 (1996).
16. Q. Ji, A. Perchellet, J. M. Goverman, Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs. Nat. Immunol. 11, 628-634 (2010).
17. J. M. M. den Haan, L. M. Meadows, W. Wang, J. Pool, E. Blokland, T. L. Bishop, C. Reinhardus, J. Shabanowitz, R. Offringa, D. F. Hunt, V. H. Engelhard, E. Goulmy, The minor histocompatibility antigen HA-1: A diallelic gene with a single amino acid polymorphism. Science 279, 1054-1057 (1998).
18. K. Kubo, K. Yamanaka, H. Kiyoi, H. Fukutani, M. Ito, R. Hayakawa, R. Ohno, T. Naoe, Different T-cell receptor repertoires between lesions and peripheral blood in acute graft-versus-host disease after allogeneic bone marrow transplantation. Blood 87, 3019-3026 (1996).
19. P. Y. Dietrich, A. Caignard, A. Diu, C. Genevee, J. L. Pico, M. Henry-Amar, J. Bosq, E. Angevin, F. Triebel, T. Hercend, Analysis of T-cell receptor variability in transplanted patients with acute graft-versus-host disease. Blood 80, 2419-2424 (1992).
20. E. J. Suchin, P. B. Langmuir, E. Palmer, M. H. Sayegh, A. D. Wells, L. A. Turka, Quantifying the frequency of alloreactive T cells in vivo: New answers to an old question. J. Immunol. 166, 973-981 (2001).
21. T. M. Friedman, K. Goldgirsh, S. A. Berger, J. Zilberberg, J. Filicko-O'Hara, N. Flomenberg, M. Donato, S. D. Rowley, R. Korngold, Overlap between in vitro donor antihost and in vivo posttransplantation TCR Vb use: A new paradigm for designer allogeneic blood and marrow transplantation. Blood 112, 3517-3525 (2008).
22. T. K. Starr, S. C. Jameson, K. A. Hogquist, Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139-176 (2003).
23. J. Zerrahn, W. Held, D. H. Raulet, The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell 88, 627-636 (1997).
24. D. Feng, C. J. Bond, L. K. Ely, J. Maynard, K. C. Garcia, Structural evidence for a germlineencoded T cell receptor-major histocompatibility complex interaction 'codon'. Nat. Immunol. 8, 975-983 (2007).
25. S. Dai, E. S. Huseby, K. Rubtsova, J. Scott-Browne, F. Crawford, W. A. Macdonald, P. Marrack, J. W. Kappler, Crossreactive T cells spotlight the germline rules for ab T cell-receptor interactions with MHC molecules. Immunity 28, 324-334 (2008).
26. J. P. Scott-Browne, J. White, J. W. Kappler, L. Gapin, P. Marrack, Germline-encoded amino acids in the ab T-cell receptor control thymic selection. Nature 458, 1043-1046 (2009).
27. E. S. Huseby, J. White, F. Crawford, T. Vass, D. Becker, C. Pinilla, P. Marrack, J. W. Kappler, How the T cell repertoire becomes peptide and MHC specific. Cell 122, 247-260 (2005).
28. G. P. Morris, P. P. Ni, P. M. Allen, Alloreactivity is limited by the endogenous peptide repertoire. Proc. Natl. Acad. Sci. U.S.A. 108, 3695-3700 (2011).
29. N. J. Felix, P. M. Allen, Specificity of T-cell alloreactivity. Nat. Rev. Immunol. 7, 942-953 (2007).
30. R. A. Morgan, M. E. Dudley, J. R. Wunderlich, M. S. Hughes, J. C. Yang, R. M. Sherry, R. E. Royal, S. L. Topalian, U. S. Kammula, N. P. Restifo, Z. Zheng, A. Nahvi, C. R. de Vries, L. J. Rogers-Freezer, S. A. Mavroukakis, S. A. Rosenberg, Cancer regression in patients after transfer of genetically engineered lymphocytes. Science 314, 126-129 (2006).
31. M. A. de Witte, M. Coccoris, M. C. Wolkers, M. D. van den Boom, E. M. Mesman, J. Y. Song, M. van der Valk, J. B. Haanen, T. N. Schumacher, Targeting self-antigens through allogeneic TCR gene transfer. Blood 108, 870-877 (2006).
32. L. A. Johnson, R. A. Morgan, M. E. Dudley, L. Cassard, J. C. Yang, M. S. Hughes, U. S. Kammula, R. E. Royal, R. M. Sherry, J. R. Wunderlich, C. C. Lee, N. P. Restifo, S. L. Schwarz, A. P. Cogdill, R. J. Bishop, H. Kim, C. C. Brewer, S. F. Rudy, C. VanWaes, J. L. Davis, A. Mathur, R. T. Ripley, D. A. Nathan, C. M. Laurencot, S. A. Rosenberg, Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen. Blood 114, 535-546 (2009).
33. G. M. Bendle, C. Linnemann, A. I. Hooijkaas, L. Bies, M. A. de Witte, A. Jorritsma, A. D. Kaiser, N. Pouw, R. Debets, E. Kieback, W. Uckert, J. Y. Song, J. B. Haanen, T. N. Schumacher, Lethal graftversus- host disease in mouse models of T cell receptor gene therapy. Nat. Med. 6, 565-570 (2010).
34. M. M. van Loenen, R. de Boer, A. L. Amir, R. S. Hagedoorn, G. L. Volbeda, R. Willemze, J. J. van Rood, J. H. Falkenburg, M. H. Heemskerk, Mixed T cell receptor dimers harbor potentially harmful neoreactivity. Proc. Natl. Acad. Sci. U.S.A. 107, 10972-10977 (2010).
35. F. T. Hakim, S. A. Memon, R. Cepeda, E. C. Jones, C. K. Chow, C. Kasten-Sportes, J. Odom, B. A. Vance, B. L. Christensen, C. L. Mackall, R. E. Gress, Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115, 930-939 (2005).
36. W. Krenger, B. R. Blazar, G. A. Holländer, Thymic T-cell development in allogeneic stem cell transplantation. Blood 117, 6768-6776 (2011).
37. H. Tuovinen, J. T. Salminen, T. P. Arstila, Most human thymic and peripheral-blood CD4+ CD25+ regulatory T cells express 2 T-cell receptors. Blood 108, 4063-4070 (2006).
38. C. S. Hsieh, H. M. Lee, C. W. Lio, Selection of regulatory T cells in the thymus. Nat. Rev. Immunol. 12, 157-167 (2012).
39. C. S. Clements, L. Kjer-Nielsen, W. A. MacDonald, A. G. Brooks, A. W. Purcell, J. McCluskey, J. Rossjohn, The production, purification and crystallization of a soluble heterodimeric form of a highly selected T-cell receptor in its unliganded and liganded state. Acta Crystallogr. D Biol. Crystallogr. 58, 2131-2134 (2002).
40. G. Köhler, C. Milstein, Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256, 495-497 (1975).